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Abstract Oxidized low density lipoprotein (OxLDL) possesses
several proatherogenic characteristics, among which a marked
cytotoxicity. In vitro, cytotoxicity of OxLDL to endothelial cells
is associated with an increase in the expression of the inducible
form of heat shock protein 70 (hsp70), generally regarded as a
cytoprotective protein. Oxidized derivatives of cholesterol which
form upon LDL oxidation are cytotoxic. Moreover, most of the
OxLDL cytotoxicity is due to its lipid moiety, in particular to
oxysterols. In this report we demonstrate that although
oxysterols identified in OxLDL are cytotoxic, they cannot
trigger the increase in hsp70 expression observed with intact
oxidized lipoproteins. We speculate therefore that oxysterols
may represent the most toxic form of oxidized lipids in LDL
because they cannot activate a rescue mechanism (i.e. the hsp
response) and may contribute significantly to cell death within
atherosclerotic plaques.
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1. Introduction
Oxidation of low density lipoprotein (LDL) is believed to
play a key role in the pathogenesis of atherosclerosis [1^3].
One of the potentially atherogenic properties of OxLDL is its
cytotoxicity to the cells of the artery wall [3,4]. Cytotoxicity of
OxLDL could initiate and worsen atherosclerosis by giving
rise to cellular dysfunction in the early stages of lesion for-
mation and by causing cell death in advanced lesions, thus
leading to the formation of a necrotic core [5,6].
Cells facing toxic stimuli rapidly and preferentially synthe-
size a family of cytoprotective proteins, the heat shock pro-
teins (hsps) [7], which can prevent damage to other cellular
proteins and allow denatured polypeptides to reacquire their
native conformation [8]. This stress response represents one of
the basic mechanisms of cellular defense. We previously re-
ported that oxidized LDL triggers the expression of the indu-
cible form of hsp70 in cultured endothelial cells, and that
hsp70 induction is closely associated with OxLDL cytotoxicity
[9]. However, the components in OxLDL responsible for
hsp70 induction are still unknown. It was demonstrated that
the cytotoxicity of Cu2-oxidized LDL could be mimicked by
its lipid extract and that two cytotoxic oxysterols, 7-keto and
7-OH, are present in OxLDL at concentrations su⁄cient to
account for the toxicity of the lipoprotein to smooth muscle
cells [10]. Therefore we evaluated whether oxysterols in
OxLDL can induce hsp70 expression in human endothelial
cells. Our results show that oxysterols in OxLDL fail to do
so, although being cytotoxic. This observation stresses the
concept that oxysterols might be the most toxic component
of oxidized LDL [11,12], by acting through mechanisms that
by-pass the induction of hsp expression.
2. Materials and methods
2.1. Sterols
Cholesterol, 7L-OH, 7-keto, 25-OH and 5,6K-epoxycholesterol were
from Sigma (St. Louis, USA). 7K-OH was from Steraloids (Wilton,
USA). 5K-hydroperoxycholest-6-en-3L-ol (5K-OOH) was synthesized
according to Nickon and Bagli [13] from 500 mg pure cholesterol
(Sigma, Sigma Grades 99% purity). 7K-hydroperoxycholest-5-en-3L-
ol (7K-OOH) was obtained by allylic isomerization of 5K-OOH
present in the mixture described above [14].
2.2. Lipoproteins
LDL (1.019^1.063 g/ml) were obtained from freshly isolated human
plasma by preparative ultracentrifugation [15] and dialyzed in PBS
containing 0.01% EDTA. Protein content was determined by the
Lowry method [16]. LDL (0.2 mg protein/ml) were oxidized with 20
WM CuSO4 for 24 h at 37‡C, as previously described [9].
2.3. Lipids
Total lipids from LDL and OxLDL were extracted with chloro-
form/methanol (2:1, vol:vol), containing 0.01% butylated hydroxyto-
luene (BHT) [17]. Lipids were separated in neutral and polar fractions
using Extract-Clean NH2 columns (500 mg/2.8 ml) (Alltech, Deer¢eld,
USA) by the method of Hughes et al. [10]. Oxysterols were obtained
by fractionation of neutral lipids on Extract-Clean NH2 column. Pu-
ri¢ed lipid fractions were dissolved in and added to the culture me-
dium.
2.4. Cells
Human umbilical vein endothelial cells (HUVEC) were isolated
according to established procedures [18], cultured under standard con-
ditions in medium M-199 containing 20% FCS, heparin (15 U/ml) and
ECGF (20 Wg/ml) (Boehringer Mannheim, Mannheim, Germany) and
used within the 4th passage. The EAhy-926 line [19], a hybridoma
with the characteristics of human endothelial cells was a kind gift of
Dr. Edgell and was cultured under standard conditions in MEM+10%
FCS and 1% HAT (5U1033 M hypoxanthine, 2U1035 M aminopter-
in, 8U1034 M thymidine).
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2.5. Immunocytochemistry
Non-con£uent cells (60 000/well) were incubated with modi¢ed lipo-
proteins or the oxysterol fraction for 12 h, then ¢xed in 3% para-
formaldehyde and processed for immunostaining, as described [9].
Mouse monoclonal antibody speci¢c for the inducible form of
hsp70 (C92F3A-5, Stressgen, Victoria, Canada) (1:200) was used, fol-
lowed by biotinylated goat anti-mouse IgG (Amersham, Little Chal-
font, UK) (1:250) and £uorescein-conjugated streptavidin (Amer-
sham, 1:100). Coverslips were mounted on microscopy slides with
glycerol:PBS (1:1), examined with a Zeiss Axioscope £uorescence
microscope and photographed using 400 ASA Diachrome ¢lm.
2.6. Immunoblotting
Cells were incubated with di¡erent concentrations of OxLDL or
lipids from OxLDL. Cells were lysed in Tris-glycine bu¡er (0.25 M
Tris, 0.173 M glycine, pH 8.5), containing 3% SDS and 1 mM PMSF
and the extracts were subjected to 10% SDS-PAGE [20], after the
addition of L-mercaptoethanol (2%), glycerol and bromophenol
blue. Electrophoresed proteins were transferred onto a nitrocellulose
membrane [21] using a Trans Blot Cell (Hoefer Scienti¢c Instruments,
San Francisco, USA). The membrane was incubated with a 1:1500
dilution of anti-hsp70 antibody, then with a 1:2000 dilution of per-
oxidase-conjugated anti-mouse IgG (Sigma). Immunocomplexes were
detected by an enhanced chemiluminescence method (ECL, Amer-
sham), followed by autoradiography and quanti¢ed by the Image
program (NIH 1.52).
2.7. Cell viability
Cell viability was evaluated by the MTT test [22] using non-con-
£uent cells incubated for 24 h with OxLDL, lipids extracted from
OxLDL, lipids or puri¢ed oxysterols exactly as previously described
[23]. Cell viability was expressed as percent ratio over control cells.
2.8. Preparation of 4-hydroxynonenal
4-Hydroxynonenal-diethylacetal (HNE-DEA) was kindly provided
by Dr. Esterbauer, Institute fu«r Biochemie, Graz, Austria. An aliquot
(0.1 ml) of HNE-DEA was dried under nitrogen to remove chloro-
form; to the residue 1 ml 1033 N HCl was added and the solution was
stirred until it became clear. The concentration was determined using
a UV-spectrum (300^200 nm).
3. Results
In previous experiments we observed that OxLDL induce
the expression of hsp70 in endothelial cells [9,24]. To verify
the relationship between OxLDL cytotoxicity and hsp70 in-
duction, HUVEC were incubated with increasing concentra-
tions of OxLDL for 24 h showing a decrease of cell viability
that was accompanied by an increase of hsp70 expression
(data not shown). This suggested that hsp70 expression may
be triggered by the same component(s) present in OxLDL that
induce toxicity, as indicated by the fact that the toxic products
were present in the total lipid extract of OxLDL, which also
induced hsp70 expression (Fig. 1). As expected, lipids from
native LDL could not induce hsp70 expression and were not
cytotoxic (data not shown).
Neutral lipids were obtained from OxLDL by mean of ami-
nopropyl columns, and further fractionated by solvent mix-
tures with increasing polarity to obtain fractions with di¡erent
composition, two of which resulted enriched in oxysterols.
These fractions when incubated with HUVEC at concentra-
Fig. 1. A: Cytotoxicity of oxysterols from OxLDL to HUVEC. Sparsely grown cells were incubated for 24 h in presence of OxLDL (400 Wg
protein/ml), lipids from OxLDL (800 Wg/ml) or the indicated concentrations of oxysterols. Cell viability was determined by the MTT test and
expressed as percent of the viability of control cells. Values are the mean þ S.D. of three determinations from a representative experiment. B:
Expression of hsp70. Cells were incubated as described above, then cellular proteins were processed for immunoblotting (see Section 2.6).
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tions corresponding to 200^1600 Wg OxLDL protein/ml did
not induce hsp70 expression, yet toxic to the cells in a con-
centration-dependent manner (Fig. 1). The other fractions
when added to HUVEC at concentrations corresponding to
400 and 800 Wg OxLDL protein/ml neither were cytotoxic nor
induced hsp70 expression (not shown).
Several oxysterols, including 7-keto, 25-OH, 7K-OH, 7L-
OH, 7K-OOH, 5K-OOH and 5,6-epoxycholesterol have been
detected in OxLDL [25,26]. Puri¢ed oxysterols were individu-
ally incubated with non-con£uent HUVEC at concentrations
corresponding to their estimated content in the OxLDL used
in our experiments (from 200 to 1600 Wg protein/ml) [25]. All
oxysterols, 7K-OOH above all, were cytotoxic to HUVEC in a
dose-dependent manner, but failed to induce hsp70 expression
(Fig. 1). This ¢nding was con¢rmed by immuno£uorescence
(Fig. 2d). Thus it appears that hsp70 induction by OxLDL is
not due to oxysterols.
Oxidation of LDL leads to the formation of a complex
array of products, many of which are more polar than oxy-
sterols (highly reactive aldehydes, lysophosphatidylcholine,
oxidized fatty acids) [5]. Immuno£uorescence results showed
that HUVEC incubated with OxLDL, total lipids or polar
lipids from OxLDL (Fig. 2a, b, e) displayed cytoplasmic stain-
ing for hsp70. Cells incubated with the neutral lipids or the
oxysterol-containing fractions showed no hsp70 staining (Fig.
2c, d), in agreement with immunoblotting data. Lyso PC dis-
solved in ethanol (100 Wg/ml) or PLA2-treated LDL (contain-
ing up to 50% of phospholipids as lyso PC) could not induce
hsp70 expression up to 400 Wg/ml of LDL protein (data not
shown). Another compound that is formed upon LDL oxida-
tion is 4-HNE [27]. We evaluated the e¡ect of 4-HNE in a
range from 0.1 WM up to 1000 WM: this compound resulted to
be toxic in a dose-dependent manner, while no induction of
hsp70 was observed at all concentrations tested (Fig. 3).
4. Discussion
De novo synthesis of stress proteins is generally regarded as
a defense response triggered by a number of toxic stimuli [7,8].
Among stress proteins, hsp70 is highly inducible and is
thought to represent an early response of stressed cells to
adverse conditions [28]. Hsp70 has been detected in areas of
atherosclerotic lesions [29] suggesting that sites of increased
hsp expression during plaque evolution represent areas of the
arterial wall experiencing cytotoxic stress [30]. Recently, we
reported that OxLDL induce the expression of hsp70 in cul-
tured human endothelial cells [9] and smooth muscle cells [23]
and hypothesized that this event may represent a cytoprotec-
tive response to OxLDL cytotoxicity. In vivo, OxLDL are
present in vascular lesions and may play a causal role in
atherosclerosis [1]. Therefore, oxidized lipoproteins could con-
tribute to cell damage associated with atherosclerosis. OxLDL
cytotoxicity can be mimicked by its lipids [10]. Several lines of
evidence point to the cytotoxicity and atherogenicity of oxy-
sterols [31,32], which are also markers for the oxidative mod-
i¢cation of lipoproteins [25,26] and have been detected in
atherosclerotic plaques [11]. Since oxysterols account for
most of OxLDL cytotoxicity [10,11] it is reasonable to spec-
ulate that they are responsible for the damage to endothelial
cells and for the loss of cells occurring in advanced athero-
sclerotic lesions. Due to the pathogenic features of oxysterols,
and because the inducible form of hsp70 can be viewed as a
marker of cells responding to toxic stimuli [28], we speculated
that oxysterols, that could represent an oxidative stress for
cells, may be responsible for hsp70 expression induced by
OxLDL. Oxysterols puri¢ed from OxLDL, either tested as a
whole mixture or individually, were cytotoxic in a dose-de-
pendent manner but neither as a mixture nor as puri¢ed mol-
ecules they could induce hsp70 expression in endothelial cells.
Oxidized cholesteryl esters were mildly cytotoxic and, like
oxysterols, did not induce hsp70 expression (data not shown).
Fig. 2. Analysis of hsp70 induction in HUVEC by immuno£uores-
cence. Sparsely grown cells were incubated for 12 h in M-199 con-
taining: (a) OxLDL (400 Wg protein/ml); (b) OxLDL total lipids
(1000 Wg/ml); (c) neutral lipids from OxLDL (1000 Wg/ml); (d) oxy-
sterols from OxLDL (1000 Wg/ml); (e) polar lipids from OxLDL
(1000 Wg/ml); (f) polar lipids from native LDL (1000 Wg/ml). Cells
were then processed for immunostaining of the inducible form of
hsp70 (see Section 2.7). Data are representatives of four di¡erent ex-
periments.
Fig. 3. Cytotoxicity and induction of hsp70 by 4-hydroxynonenal in
EAhy-926. Sparsely grown cells were incubated for 18 h with in-
creasing concentrations of 4-HNE (0.1 to 1000 WM). Cell viability
was determined by the MTT test and expressed as percent ratio
over the viability of control cells. For immunoblotting experiments,
the inducible form of hsp70 was investigated with a speci¢c mono-
clonal antibody. P6 0.005 vs. control.
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Thus, although hsp70 induction is associated with OxLDL
toxicity, not every toxic component of OxLDL can induce
hsp70 expression. These data therefore suggest that the pres-
ence of hsp70 in atherosclerotic plaques [33] is not caused by
the presence of toxic oxysterols, and that other components of
OxLDL must be responsible for this e¡ect.
In a toxic environment, the increase in hsp synthesis is
generally linked to the presence of protein denaturants [7,8].
It could be that oxysterols do not trigger a stress response
because, rather than being proteotoxic, they are in fact inter-
fering with essential steps of cellular metabolism, as it is
known for some oxidized derivatives of cholesterol that block
protein synthesis [34,35]. Because oxysterols and other neutral
lipids failed to induce hsp70 expression in HUVEC while po-
lar lipids were e¡ective, we tested a major polar product
formed upon oxidation of LDL, 4-hydroxynonenal (4-HNE)
[27]. This molecule induces hsp70 in cultured hepatoma cells
[36]. When 4-HNE was added to endothelial cells we found a
dose-dependent cytotoxicity, while no induction of hsp70 was
found in this cell system.
In summary, our observations point to the concept that
cytotoxicity of oxidized LDL is mediated in part by oxyster-
ols, and that this toxic e¡ect does not induce the heat shock
response elicited by OxLDL. We therefore propose that two
major classes of oxidized products are present in OxLDL: one
responsible for the cytotoxic e¡ect but not able to induce heat
shock response (mainly oxysterols) ; the other, which is less
toxic, mediates the induction of hsp70. The balance between
these components may result in cell survival versus cells death
at sites where OxLDL are present.
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